Paul Yeung

3.2k total citations · 2 hit papers
84 papers, 2.1k citations indexed

About

Paul Yeung is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, Paul Yeung has authored 84 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Psychiatry and Mental health, 14 papers in Pharmacology and 9 papers in Clinical Psychology. Recurrent topics in Paul Yeung's work include Migraine and Headache Studies (30 papers), Schizophrenia research and treatment (12 papers) and Attention Deficit Hyperactivity Disorder (10 papers). Paul Yeung is often cited by papers focused on Migraine and Headache Studies (30 papers), Schizophrenia research and treatment (12 papers) and Attention Deficit Hyperactivity Disorder (10 papers). Paul Yeung collaborates with scholars based in United States, Australia and United Kingdom. Paul Yeung's co-authors include Stephen D. Silberstein, Ronghua Yang, Ernesto Aycardi, Peter J. Goadsby, David W. Dodick, Yuju Ma, Melissa Grozinski‐Wolff, Tricia Blankenbiller, Marcelo E. Bigal and Nadia R. Kunz and has published in prestigious journals such as New England Journal of Medicine, JAMA and American Journal of Psychiatry.

In The Last Decade

Paul Yeung

78 papers receiving 2.0k citations

Hit Papers

Fremanezumab for the Preventive Treatment of Chronic Migr... 2017 2026 2020 2023 2017 2018 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Fremanezumab for the Preventive Treatment of Chronic Migraine
    2017 544 citations David W. Dodick, Paul Yeung et al. profile →
  2. Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine
    2018 367 citations David W. Dodick, Paul Yeung et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Yeung United States 20 1.6k 809 506 280 270 84 2.1k
Virginia L. Stauffer United States 30 2.3k 1.4× 614 0.8× 427 0.8× 400 1.4× 296 1.1× 85 2.7k
Vincent T. Martin United States 33 2.8k 1.7× 1.4k 1.7× 1.1k 2.1× 309 1.1× 156 0.6× 86 3.5k
Ana Recober United States 22 1.1k 0.7× 320 0.4× 324 0.6× 301 1.1× 130 0.5× 37 1.6k
Jan Lewis Brandes United States 36 4.4k 2.7× 2.8k 3.5× 1.8k 3.5× 357 1.3× 131 0.5× 73 5.0k
Manolis Markianos Greece 24 638 0.4× 167 0.2× 169 0.3× 326 1.2× 202 0.7× 153 2.0k
Nancy L. Earl United States 13 1.3k 0.8× 207 0.3× 245 0.5× 175 0.6× 131 0.5× 23 1.8k
Elena P. Calandre Spain 27 1.3k 0.8× 134 0.2× 358 0.7× 240 0.9× 760 2.8× 67 2.0k
Seymour Diamond United States 29 4.5k 2.8× 2.6k 3.2× 1.8k 3.6× 193 0.7× 300 1.1× 160 5.4k
Panagiotis Ferentinos Greece 22 519 0.3× 107 0.1× 154 0.3× 283 1.0× 206 0.8× 116 1.5k
Grazia Dell’Agnello Italy 25 961 0.6× 98 0.1× 308 0.6× 226 0.8× 85 0.3× 50 1.9k

Countries citing papers authored by Paul Yeung

Since Specialization
Citations

This map shows the geographic impact of Paul Yeung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Yeung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Yeung more than expected).

Fields of papers citing papers by Paul Yeung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Yeung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Yeung. The network helps show where Paul Yeung may publish in the future.

Co-authorship network of co-authors of Paul Yeung

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Yeung. A scholar is included among the top collaborators of Paul Yeung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Yeung. Paul Yeung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thase, Michael E., et al.. (2024). Safety and tolerability of cariprazine for the adjunctive treatment of major depressive disorder: a pooled analysis of phase 2b/phase 3 clinical trials. International Clinical Psychopharmacology. 40(1). 27–36. 3 indexed citations
2.
Riesenberg, Robert, et al.. (2023). Cariprazine for the Adjunctive Treatment of Major Depressive Disorder in Patients With Inadequate Response to Antidepressant Therapy. The Journal of Clinical Psychiatry. 84(5). 9 indexed citations
3.
Yeung, Paul, Robert Riesenberg, Amelia Orejudos, et al.. (2023). Cariprazine in Pediatric Patients with Autism Spectrum Disorder: Results of a Pharmacokinetic, Safety and Tolerability Study. Journal of Child and Adolescent Psychopharmacology. 33(6). 232–242. 4 indexed citations
4.
5.
6.
Riccobene, Todd, Robert Riesenberg, Paul Yeung, Willie Earley, & Arlene Hankinson. (2022). Pharmacokinetics, Safety, and Tolerability of Cariprazine in Pediatric Patients with Bipolar I Disorder or Schizophrenia. Journal of Child and Adolescent Psychopharmacology. 32(8). 434–443. 5 indexed citations
7.
8.
9.
Lipton, Richard B., Joshua M. Cohen, Paul Yeung, et al.. (2019). Long-Term Efficacy of Fremanezumab in Patients With Chronic Migraine and Comorbid Moderate to Severe Depression (P1.10-024). Neurology. 92(15_supplement). 1 indexed citations
10.
11.
McAllister, Peter, et al.. (2019). Efficacy of Fremanezumab in Migraine Patients Who Have Failed at Least One Prior Migraine Preventive Medication (P1.10-011). Neurology. 92(15_supplement). 2 indexed citations
12.
Singh, Rashmi B. Halker, Michael J. Marmura, Joshua M. Cohen, Paul Yeung, & Ronghua Yang. (2019). Improvement in Response Over Time With Fremanezumab in Patients Who Reverted From a Chronic to an Episodic Migraine Classification (P1.10-013). Neurology. 92(15_supplement).
13.
Winner, Paul, Timothy Fitzgerald, Sanjay Gandhi, et al.. (2018). The Impact of Fremanezumab on Headache-Related Disability in Patients with Episodic Migraine using the Migraine Disability Assessment (P4.095). Neurology. 90(15_supplement). 1 indexed citations
14.
Lipton, Richard B., Sanjay Gandhi, Timothy Fitzgerald, et al.. (2018). The Positive Impact of Fremanezumab on Work Productivity and Activity Impairment in Patients with Chronic Migraine (S32.007). Neurology. 90(15_supplement). 1 indexed citations
15.
Landsman‐Blumberg, Pamela, Nathaniel P. Katz, Kavita Gajria, et al.. (2017). Health care resource use and cost differences by opioid therapy type among chronic noncancer pain patients. Journal of Pain Research. Volume 10. 1713–1722. 6 indexed citations
16.
Zeller, Scott L., Leslie S. Zun, James V. Cassella, Daniel A. Spyker, & Paul Yeung. (2017). Response to inhaled loxapine in patients with schizophrenia or bipolar I disorder: PANSS-EC responder analyses. BJPsych Open. 3(6). 285–290. 8 indexed citations
17.
Rynn, Moira A., Mark A. Riddle, Paul Yeung, & Nadia R. Kunz. (2007). Efficacy and Safety of Extended-Release Venlafaxine in the Treatment of Generalized Anxiety Disorder in Children and Adolescents: Two Placebo-Controlled Trials. American Journal of Psychiatry. 164(2). 290–300. 100 indexed citations
18.
Yeung, Paul, Pierre N. Tariot, Lon S. Schneider, Carl Salzman, & Ihor W Rak. (2000). Quetiapine for Elderly Patients With Psychotic Disorders. Psychiatric Annals. 30(3). 197–201. 19 indexed citations
19.
Yeung, Paul, et al.. (1998). Exposure of Air Blast Applicators to Ethyl Parathion and Methyl Parathion in Orchards: A Comparison of Australian Conditions to Overseas Predictive Exposure Models. Applied Occupational and Environmental Hygiene. 13(4). 242–251. 5 indexed citations
20.
McDougle, Christopher J., et al.. (1995). Risperidone in Adults with Autism or Pervasive Developmental Disorder. Journal of Child and Adolescent Psychopharmacology. 5(4). 273–282. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Virginia L. Stauffer Breakdown of academic impact, for papers by Vincent T. Martin Breakdown of academic impact, for papers by Ana Recober Breakdown of academic impact, for papers by Jan Lewis Brandes Breakdown of academic impact, for papers by Manolis Markianos Breakdown of academic impact, for papers by Nancy L. Earl Breakdown of academic impact, for papers by Elena P. Calandre Breakdown of academic impact, for papers by Seymour Diamond Breakdown of academic impact, for papers by Panagiotis Ferentinos Breakdown of academic impact, for papers by Grazia Dell’Agnello
Rankless by CCL
2026